Loading...
ROCO
6469
Market cap364mUSD
Jul 09, Last price  
78.00TWD
1D
1.43%
1Q
-2.99%
Jan 2017
300.82%
IPO
395.87%
Name

Great Tree Pharmacy Co Ltd

Chart & Performance

D1W1MN
ROCO:6469 chart
P/E
19.48
P/S
0.62
EPS
4.00
Div Yield, %
3.74%
Shrs. gr., 5y
5.82%
Rev. gr., 5y
16.94%
Revenues
18.90b
+9.39%
911,062,6531,136,190,0001,662,431,0002,159,857,0002,802,016,0003,623,734,0004,900,729,0006,601,612,0008,641,394,00011,280,942,00014,564,645,00016,143,701,00017,274,254,00018,895,916,000
Net income
600m
-11.80%
33,789,41268,100,00095,854,00077,466,00092,865,000102,418,000106,002,000135,985,000194,311,000407,418,000700,071,000666,049,000680,767,000600,421,000
CFO
1.17b
+2.38%
36,853,96654,527,00094,555,000-3,156,000129,149,000156,851,000131,331,000224,888,000728,128,0001,077,660,0001,226,695,000890,331,0001,138,673,0001,165,793,000
Dividend
Jul 01, 20253.2949 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Great Tree Pharmacy Co., Ltd. is a Taiwanese enterprise that operates an extensive chain of pharmacies throughout the island nation. These retail outlets offer a broad selection of goods, including prescription and over-the-counter medications, nutritional supplements, products specifically for mothers and infants, and various cosmetics. Beyond its retail presence, the company also delivers comprehensive medication procurement and coordination services to medical establishments such as individual clinics, shared outpatient facilities, and larger integrated healthcare networks. Furthermore, Great Tree Pharmacy acts as an agent for these same medical institutions, assisting them in the distribution and sale of popular health and wellness products sourced both domestically and internationally. Established in 2001, the company was initially named Tianjin Pharmaceutical Co., Ltd. before rebranding to its current designation. Its main corporate offices are located in Taoyuan City, Taiwan.
IPO date
Dec 29, 2014
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT